Skip to main content

PSY - Defiance Next Gen Altered Experience ETF


PSY - Defiance Next Gen Altered Experience ETF

Psychedelics future

Imagine if a non-addictive, short term intervention with minimal side effects could dramatically improve mental health? Psychedelics could be a part of such treatment.

Next Gen. Medicine

Psychedelics promote neural plasticity, essentially allowing the brain to rewire itself. Recipients report unparalleled insight and paradigm shifts akin to mystical or spiritual awakenings.

Growth Potential

Psilocybin, LSD and their derivatives could become an integral part of the multi-billion dollar global medicine market; offering hope to many whose conditions seem untreatable in current paradigms.


PSY is also a cannabis ETF offering exposure to companies leading the medical repurposing of cannabis, to treat chronic pain, symptoms of MS, and side effects of chemotherapy among others.